Changchun High & New Technology Industries Group Inc (000661) - Total Liabilities

Latest as of March 2026: CN¥5.63 Billion CNY ≈ $824.13 Million USD

Based on the latest financial reports, Changchun High & New Technology Industries Group Inc (000661) has total liabilities worth CN¥5.63 Billion CNY (≈ $824.13 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Changchun High & New Technology Industries Group Inc - Total Liabilities Trend (1993–2025)

This chart illustrates how Changchun High & New Technology Industries Group Inc's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Changchun High & New Technology Industri's working capital to evaluate short-term liquidity relative to the company's equity base.

Changchun High & New Technology Industries Group Inc Competitors by Total Liabilities

The table below lists competitors of Changchun High & New Technology Industries Group Inc ranked by their total liabilities.

Company Country Total Liabilities
First BanCorp.
NYSE:FBP
USA $17.12 Billion
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
USA $134.91 Million
Huaihe Energy Group Co Ltd
SHG:600575
China CN¥25.50 Billion
Graham Holdings Co
NYSE:GHC
USA $3.38 Billion
Shanghai Phichem Material Co Ltd Class A
SHE:300398
China CN¥1.96 Billion
Cleanaway Waste Management Ltd
AU:CWY
Australia AU$4.10 Billion
JB Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM
India Rs8.09 Billion
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
Korea ₩174.97 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Changchun High & New Technology Industries Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Changchun High & New Technology Industri.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.52 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.25 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Changchun High & New Technology Industries Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Changchun High & New Technology Industries Group Inc (1993–2025)

The table below shows the annual total liabilities of Changchun High & New Technology Industries Group Inc from 1993 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥5.21 Billion
≈ $762.53 Million
+5.30%
2024-12-31 CN¥4.95 Billion
≈ $724.15 Million
-13.35%
2023-12-31 CN¥5.71 Billion
≈ $835.76 Million
+9.37%
2022-12-31 CN¥5.22 Billion
≈ $764.18 Million
-1.07%
2021-12-31 CN¥5.28 Billion
≈ $772.48 Million
+15.21%
2020-12-31 CN¥4.58 Billion
≈ $670.51 Million
+17.08%
2019-12-31 CN¥3.91 Billion
≈ $572.71 Million
+26.66%
2018-12-31 CN¥3.09 Billion
≈ $452.16 Million
+43.65%
2017-12-31 CN¥2.15 Billion
≈ $314.77 Million
+22.70%
2016-12-31 CN¥1.75 Billion
≈ $256.53 Million
+27.00%
2015-12-31 CN¥1.38 Billion
≈ $201.98 Million
+25.05%
2014-12-31 CN¥1.10 Billion
≈ $161.52 Million
-0.25%
2013-12-31 CN¥1.11 Billion
≈ $161.92 Million
+9.50%
2012-12-31 CN¥1.01 Billion
≈ $147.87 Million
-9.15%
2011-12-31 CN¥1.11 Billion
≈ $162.77 Million
+16.15%
2010-12-31 CN¥957.70 Million
≈ $140.14 Million
+11.38%
2009-12-31 CN¥859.88 Million
≈ $125.83 Million
-11.91%
2008-12-31 CN¥976.09 Million
≈ $142.83 Million
-3.77%
2007-12-31 CN¥1.01 Billion
≈ $148.43 Million
+4.51%
2006-12-31 CN¥970.53 Million
≈ $142.02 Million
-2.52%
2005-12-31 CN¥995.65 Million
≈ $145.69 Million
+6.00%
2004-12-31 CN¥939.29 Million
≈ $137.45 Million
-14.96%
2003-12-31 CN¥1.10 Billion
≈ $161.64 Million
+69.55%
2002-12-31 CN¥651.47 Million
≈ $95.33 Million
-4.83%
2001-12-31 CN¥684.54 Million
≈ $100.17 Million
+15.37%
2000-12-31 CN¥593.35 Million
≈ $86.83 Million
+6.41%
1999-12-31 CN¥557.63 Million
≈ $81.60 Million
+3.60%
1998-12-31 CN¥538.28 Million
≈ $78.77 Million
+26.38%
1997-12-31 CN¥425.93 Million
≈ $62.33 Million
+11.08%
1996-12-31 CN¥383.46 Million
≈ $56.11 Million
+11.85%
1995-12-31 CN¥342.85 Million
≈ $50.17 Million
+59.54%
1994-12-31 CN¥214.90 Million
≈ $31.45 Million
+29.87%
1993-12-31 CN¥165.47 Million
≈ $24.21 Million
--

About Changchun High & New Technology Industries Group Inc

SHE:000661 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.83 Billion
CN¥26.15 Billion CNY
Market Cap Rank
#4307 Global
#717 in China
Share Price
CN¥64.10
Change (1 day)
+0.49%
52-Week Range
CN¥63.79 - CN¥136.30
All Time High
CN¥1174.87
About

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasa… Read more